Skip to content

Optimizing Outcome of Transobturator vaginal wall sling (Elgamasy Technique) versus transobturator tape (TOT) for female stress urinary incontinence (SUI); randomized controlled clinical trial

Optimizing Outcome of Transobturator vaginal wall sling (Elgamasy Technique) versus transobturator tape (TOT) for female stress urinary incontinence (SUI); randomized controlled clinical trial

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202412561562309
Enrollment
60
Registered
2024-12-04
Start date
2024-10-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological and Genital Diseases

Interventions

autologous vaginal wall sling

Sponsors

Tanta University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ? Females patients with stress urinary incontinence and clinically positive cough stress test. ? Females patients with mixed urinary incontinence with predominant of stress component.

Exclusion criteria

Exclusion criteria: • Patient with history of failed previous incontinence surgical management. • Patient complaining from stress urinary incontinence but with negative stress test. • Patient complaining from mixed urinary incontinence with prominent urge component. • Current pregnancy. • Urogenital malignancy • Neurological disease • Bleeding disorders. • Morbidly obese patients (BMI more than 40 kg/m2) • High post-voiding residual urine volume (> 150 ml) or presence of underactive detrusor. • Active urinary tract infection. • Grade 3 pelvic organ prolapse. • History of pelvic irradiation.

Design outcomes

Primary

MeasureTime frame
oObjective cure (objective cure defines as having a negative stress test and no pad use per day. Subjective improvements in (ICIQ-UI SF) score.

Secondary

MeasureTime frame
o Operative time, VAS on post-operative days 1 and 5 and, hospital stay, cost-effectiveness and complications.

Countries

Egypt

Contacts

Public ContactAhmed Eissa

lecturer

Ahmed.taha.eissa@gmail.com2001069920293

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026